You have 9 free searches left this month | for more free features.

Drug Therapy

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Muscle Invasive Bladder Carcinoma Trial in Beijing (RC48-ADC, AK104)

Recruiting
  • Muscle Invasive Bladder Carcinoma
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Oct 6, 2023

Iron Deficiency Anemia Trial (Triferic AVNU, Placebo)

Not yet recruiting
  • Iron Deficiency Anemia
  • Triferic AVNU
  • Placebo
  • (no location specified)
Oct 26, 2021

Androgen Deprivation-related Sarcopenia

Recruiting
  • Metastatic Prostate Cancer
  • Androgen Deprivation Therapy
  • GnRH agonist
  • Seattle, Washington
    Veterans Affairs Puget Sound Health Care System
Mar 16, 2022

Sarcoma Trial in France (Nivolumab and IPILIMUMAB, Pazopanib Oral Tablet [Votrient])

Recruiting
  • Sarcoma
  • Nivolumab and IPILIMUMAB
  • Pazopanib Oral Tablet [Votrient]
  • Lyon, Rhône, France
  • +10 more
Jun 22, 2022

Plaque Psoriasis Trial (Apremilast, Placebo, Topical treatments or phototherapy)

Completed
  • Plaque Psoriasis
  • (no location specified)
Mar 3, 2022

Unresectable Metastatic Colorectal Cancer Trial (Bifico combined with chemo plus targeted therapy, chemo plus targeted therapy)

Not yet recruiting
  • Unresectable Metastatic Colorectal Cancer
  • Bifico combined with chemotherapy plus targeted therapy
  • chemotherapy plus targeted therapy
  • (no location specified)
Jul 13, 2021

Breast Cancer, Climacteric Symptoms Trial (tibolone, )

Completed
  • Breast Cancer
  • Climacteric Symptoms
  • (no location specified)
Feb 2, 2022

Covid19, Lymphopenia Trial in Shenyang (nicotinamide)

Completed
  • Covid19
  • Lymphopenia
  • Shenyang, Liaoning, China
    General Hospital of Northern Theater Command
Oct 29, 2021

Gastrointestinal Neuroendocrine Carcinoma Trial in Beijing (Durvalumab and Chemotherapy(oxaliplatin and capecitabine))

Recruiting
  • Gastrointestinal Neuroendocrine Carcinoma
  • Durvalumab and Chemotherapy(oxaliplatin and capecitabine)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 1, 2023

Advanced Solid Tumor Trial in Los Angeles (EP0031)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +3 more
Dec 1, 2022

Atrial Fibrillation Trial in Indianapolis (Ondansetron 8mg, Placebo)

Not yet recruiting
  • Atrial Fibrillation
  • Ondansetron 8mg
  • Placebo
  • Indianapolis, Indiana
  • +2 more
Apr 25, 2023

Alzheimer Trial in Atlanta (Montelukast, Placebo oral tablet)

Active, not recruiting
  • Alzheimer Disease
  • Atlanta, Georgia
  • +3 more
Nov 16, 2021

Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

Not yet recruiting
  • Breast Cancer Invasive
  • +3 more
  • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023

COVID-19 Trial in Worldwide (XAV-19, Placebo)

Terminated
  • COVID-19
  • Dimitrovgrad, Bulgaria
  • +17 more
Jan 19, 2023

Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)

Active, not recruiting
  • Chronic Hepatitis B
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Apr 20, 2023

Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)

Recruiting
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +128 more
Aug 24, 2022

Subcutaneous Fat Disorder Trial (10XB-101 Solution for Injection, 6.0%, Placebo Solution for Injection (no active ingredient))

Not yet recruiting
  • Subcutaneous Fat Disorder
  • 10XB-101 Solution for Injection, 6.0%
  • Placebo Solution for Injection (no active ingredient)
  • (no location specified)
Feb 27, 2023

Complex Regional Pain Syndrome Trial in Cleveland (Nitrous Oxide, Oxygen)

Enrolling by invitation
  • Complex Regional Pain Syndrome
  • Cleveland, Ohio
    Cleveland Clinic Pain Management
Jan 10, 2022

Substance Use Disorders, PTSD Trial in Aurora, Centennial, Denver (RRFT (Risk Reduction through Family Therapy), ENCOMPASS

Recruiting
  • Substance Use Disorders
  • PTSD
  • RRFT (Risk Reduction through Family Therapy)
  • ENCOMPASS (Integrated Treatment for Adolescents and Young Adults)
  • Aurora, Colorado
  • +2 more
Aug 2, 2022

Radium-223 is and How Well it Works in Chinese Advanced Prostate

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Bone Metastases
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, China
    Many locations
Aug 10, 2022

Obstructive Sleep Apnea of Adult Trial in New York (Atorvastatin 10mg, Placebo, Continuous Positive Airway Pressure Therapy)

Recruiting
  • Obstructive Sleep Apnea of Adult
  • Atorvastatin 10mg
  • +2 more
  • New York, New York
    Columbia University Irving Medical Center
Jan 25, 2023

Chronyc Myeloid Leukemia Trial in Italy, Netherlands (Imatinib, Nilotinib)

Active, not recruiting
  • Chronyc Myeloid Leukemia
  • Alessandria, Italy
  • +81 more
Jan 4, 2022

Ischemic Stroke Trial in Hangzhou (Nerver growth factor (NGF) injection, Placebo injection, EA intervention)

Recruiting
  • Ischemic Stroke
  • Nerver growth factor (NGF) injection
  • +3 more
  • Hangzhou, Zhejiang, China
    The Third Affiliated Hospital of Zhejiang Chinese Medical Univer
Jul 26, 2022

Squamous Cell Carcinoma Trial in France (Onivyde, Paclitaxel)

Recruiting
  • Squamous Cell Carcinoma
  • Amiens, France
  • +8 more
Dec 6, 2021

Leukemia Trial in Houston (MEK 162)

Terminated
  • Leukemia
  • MEK 162
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 25, 2021